AI assistant
Sending…
BerGenBio — Director's Dealing 2023
Jun 8, 2023
3555_dirs_2023-06-08_fdd205f9-3b71-422f-bb8c-695300f2eaf5.pdf
Director's Dealing
Open in viewerOpens in your device viewer
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Martin Olin | ||
| 2 | Reason for the notification | |||
| a) | Position/status | CEO, primary insider | ||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Exercise of subscription rights (ISIN NO001292118) to shares in BerGenBio ASA (ISIN NO0010650013). |
||
| b) | Nature of the transaction | Exercise of rights | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0.10 | 1 046 125 | |||
| d) | Aggregated information | |||
| — Aggregated volume |
1 046 125 subscription rights for NOK 0.10. | |||
| — Price |
||||
| e) | Date of the transaction | 2023-06-05 | ||
| f) | Place of the transaction | Outside a trading venue |
More from BerGenBio
M&A Activity
2025
Oct 29
Delisting Announcement
2025
Oct 29
Capital/Financing Update
2025
Oct 28
M&A Activity
2025
Oct 24
Share Issue/Capital Change
2025
Sep 17
Share Issue/Capital Change
2025
Sep 17
Interim / Quarterly Report
2025
Aug 20
Earnings Release
2025
Aug 20
Share Issue/Capital Change
2025
Aug 5
Declaration of Voting Results & Voting Rights Announcements
2025
Aug 4